Status:
COMPLETED
Civilian Post-Traumatic Stress Disorder Risperidone Clinical Trial
Lead Sponsor:
Emory University
Collaborating Sponsors:
Janssen, LP
Conditions:
Post-Traumatic Stress Disorders
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this study is to determine whether the administration of risperidone is effective in the treatment of selective serotonin reuptake inhibitor (SSRI)-resistant post-traumatic stress disor...
Detailed Description
Individuals with PTSD often experience anxiety attacks, nightmares, or repeated unwanted memories after experiencing or witnessing life-threatening events, such as serious accidents or natural disaste...
Eligibility Criteria
Inclusion
- Meets criteria for DSM-IV PTSD for a minimum of one month duration
- Clinician-Administered PTSD Scale (CAPS) score \> or = to 50
- Able to read and complete questionnaires and interviews
- Negative urine drug screen
Exclusion
- Pregnant or nursing
- Primary psychotic disorder; psychotic disorder; or cognitive disorder.
- Prominent suicidal or homicidal ideation
- Alcohol or substance dependence within 3 months of starting study
- Primary anxiety disorder or bipolar disorder
- Patients currently being treated with antipsychotic medication
- Patients in active psychotherapy aimed at PTSD
- Combat-related PTSD
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
End Date :
September 1 2006
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT00133822
Start Date
April 1 2004
End Date
September 1 2006
Last Update
August 19 2015
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University School of Medicine
Atlanta, Georgia, United States, 30322
2
Duke University Medical Center South
Durham, North Carolina, United States, 27710
3
Medical University of South Carolina
Charleston, South Carolina, United States